News & stories

Sebia receives U.S. FDA Clearance for the CAPILLARYS 3 DBS devicess
The next generation instrument for screening hemoglobin disorders in newborns.
To see or not A1c? HbA1c utilization in light of recent lab guidelines
Educational Webinar with Dr. Matthew C. Wagner
Unlocking the power of anti-MCV detection for early diagnosis of Rheumatoid Arthritis
Educational Webinar with Holger Bang, PhD & Roberto Fiorillo
Sebia receives U.S. FDA Clearance for the FLC Kappa & Lambda assays
Expanding offering for Multiple Myeloma and AL Amyloidosis Testing.
How External Quality Assessment supports quality improvement in laboratory hemoglobinopathy diagnosis
Educational Webinar with Dr Barbara De la Salle
Current Status of Detecting Monoclonal Antibodies and Free Light Chains in Serum
Educational Webinar with Dr. Matthias Orth